FinanzNachrichten.de
Biotech Stocks At 52-Week Highs - MediciNova +8%, Revvity +8%, 10x Genomics +6%, Telix Pharmaceuticals +9%, Schrodinger Inc. +12%
xCruzo Brief
A wave of biotech gains pushed several stocks to 52-week highs on September 15, 2026. MediciNova rose 8% to $2.07, with momentum tied to clinical and financial results around its late-stage pipeline, including MN-166 (ibudilast) in Phase 3 trials for ALS and DCM and planned expansion into Phase 3 for progressive MS. Revvity hit a 52-week peak of $140.21, closing up 9.11% after posting second-quarter revenue of $730 million and raising full-year guidance to $2.83 billion–$2.86 billion. Telix Pharmaceuticals reached $13.11 after FDA approval for Pixclara (floretyrosine F 18). 10x Genomics climbed over 6% to $75.61.
xCruzo quick-read summary • Source: FinanzNachrichten.de • Read the full article for complete information.
xCruzo
Health Secretary Kennedy Jr. adds eight new members to key health committee By Reuters
La Abadía presenta 'Órgia', propuesta escénica que pone el foco en la salud mental desde una mirada feminista
Senate panel sets hearing for Trump's FDA pick By Reuters
Barcelona descarta a nuevo patrocinador por su asociación con Luís Figo
Midlothian mum dismissed by doctors hits out as women 'suffering avoidable deaths' in Scotland
NHS: 20 women had unnecessary mastectomies, while others suffered harm
Los mejores piensos secos para perros adultos medianos y activos | BURGOSconecta
Los tres consejos de una ginecóloga para tomar Omega-3 | La Verdad